Anti-Human SOST Recombinant Antibody(Blosozumab)
-
产品编号
YR1254
-
别名
科研级 Blosozumab ( 布索组单抗 ), Anti-SOST Recombinant Antibody, Research Grade Blosozumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Blosozumab ( 布索组单抗 ), Anti-SOST Recombinant Antibody, Research Grade Blosozumab |
Catalog Number | YR1254 |
Molecular Name | Blosozumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG4 Kappa |
Formulation | PBS, pH7.5 |
Background | Blosozumab binds SOST, a negative regulator of osteoblast activity. Blocking SOST activity can lead to increased bone density. Blosozaumab has been studied with regards to the treatment of osteoporosis in both men and postmenopausal women. Clinical trials with Blosozumab have shown the antibody to be well tolerated and effective in producing a bone anabolic effect. |
CAS Number | 1132758-87-2 |
Application | FuncS, IF, Neut, ELISA, FCM, IP |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | SOST[Homo sapiens] |